No FDA Funding Boost In Senate HELP GOP Members' Innovation Bill
This article was originally published in The Tan Sheet
Executive Summary
HELP Chairman Alexander says FDA should receive gradual appropriations increases, rather than part of "surge" in funding proposed for NIH.
You may also be interested in...
Pediatric Rare Disease Voucher Program Faces Expiration
Stakeholders push Congress to renew program, although 21st Century Cures route unlikely.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
US FDA Hopes Food, Inspection Office Reorg Bolsters Innovative Clinical Trial Adoption
Ensuring inspectors understand the innovative trial designs in use before an inspection will be important to increasing industry confidence in their use, CDER Director Patrizia Cavazzoni said.